Jong Ho Cha, Eungu Kang, Jae Yoon Na, Soorack Ryu, Young-Jin Choi, Ja Hye Kim
{"title":"Growth Trajectories of Children Born Preterm and Full-Term With Low Birth Weight to Preschool Ages: A Nationwide Study.","authors":"Jong Ho Cha, Eungu Kang, Jae Yoon Na, Soorack Ryu, Young-Jin Choi, Ja Hye Kim","doi":"10.1210/clinem/dgae208","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Preterm (PT) and full-term with low birth weight (FT-LBW) children are at a high-risk of poor growth outcomes.</p><p><strong>Objective: </strong>This work aimed to investigate the growth trajectories of PT and FT-LBW children from birth to preschool ages.</p><p><strong>Methods: </strong>This study included 1 150 508 infants (PT, 41 454; FT-LBW, 38 250) who underwent the first 3 rounds (4-6, 9-12, and 18-24 months) of the National Health Screening Program for Infants and Children (NHSPIC). Growth measurements were obtained from the NHSPIC database and converted into Z-scores. Growth data at ages 2, 4, and 6 years were measured as outcome variables. The effect of being born small on poor growth outcomes was investigated using a generalized estimating equation and Cox proportional-hazards regression analysis.</p><p><strong>Results: </strong>The median birth weights of the PT, FT-LBW, and FT groups were 2.3, 2.4, and 3.2 kg, respectively. The incidence of short stature (height Z-score < -2 SD score [SDS]) and failure to thrive (FTT) (body mass index (BMI) Z-score < -2 SDS) was the highest in the FT-LBW group, followed by the PT and FT groups. At age 4 years, the incidence rates were 6.0% vs 5.2% vs 1.9% for short stature and 4.6% vs 3.9% vs 1.7% for FTT. The β estimate of height outcome was lower both in the PT (-0.326 SDS) and FT-LBW (-0.456 SDS) groups.</p><p><strong>Conclusion: </strong>The FT-LBW group was consistently shorter and lighter throughout the preschool period than the PT group, highlighting the significance of growth monitoring in high-risk populations.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e283-e293"},"PeriodicalIF":5.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae208","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Context: Preterm (PT) and full-term with low birth weight (FT-LBW) children are at a high-risk of poor growth outcomes.
Objective: This work aimed to investigate the growth trajectories of PT and FT-LBW children from birth to preschool ages.
Methods: This study included 1 150 508 infants (PT, 41 454; FT-LBW, 38 250) who underwent the first 3 rounds (4-6, 9-12, and 18-24 months) of the National Health Screening Program for Infants and Children (NHSPIC). Growth measurements were obtained from the NHSPIC database and converted into Z-scores. Growth data at ages 2, 4, and 6 years were measured as outcome variables. The effect of being born small on poor growth outcomes was investigated using a generalized estimating equation and Cox proportional-hazards regression analysis.
Results: The median birth weights of the PT, FT-LBW, and FT groups were 2.3, 2.4, and 3.2 kg, respectively. The incidence of short stature (height Z-score < -2 SD score [SDS]) and failure to thrive (FTT) (body mass index (BMI) Z-score < -2 SDS) was the highest in the FT-LBW group, followed by the PT and FT groups. At age 4 years, the incidence rates were 6.0% vs 5.2% vs 1.9% for short stature and 4.6% vs 3.9% vs 1.7% for FTT. The β estimate of height outcome was lower both in the PT (-0.326 SDS) and FT-LBW (-0.456 SDS) groups.
Conclusion: The FT-LBW group was consistently shorter and lighter throughout the preschool period than the PT group, highlighting the significance of growth monitoring in high-risk populations.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.